SonarMD, LLC runs a digital platform that monitors patients with inflammatory bowel disease and supports early intervention.
Founded in 2015 and headquartered in Elgin, US, SonarMD, LLC monitors patients with Crohn's disease and ulcerative colitis through monthly health assessments sent by secure email or text, based on validated clinical surveys. It works with healthcare providers and health plans on a value-based care model, sharing savings and charging patients no fee. The company raised USD 10.5 mn in Series A funding on December 17, 2018, from Arboretum Ventures and BlueCross BlueShield Venture Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in